Marketing, GTM - HCP, Medical, Digital, Communication, Strategy, Training, Marketing, New Product Launches, Commercial Excellence

Heading the Rx marketing for Anti-acne, Hperpigmentation and Cetaphil range. Strategizing and driving the OTX switch of Biluma(Skin brightening range). Conceptualizing and building inroads for the launch of OTC range in the Acne segment.

Responsible for integration of the DEOH portfolio to AlconComplete turnaround of the portfolio form a negative growth trajectory to a robust double digit growthPortfolio augmentation through new product identification & launchStrategic planning to foray into complimentary therapy areas to boost growthSetting up & managing third party field force

Handling the entire anti fungal portfolio which is the largest in the derma SBU. Managing PLC of the existing brands & responsible for launching new & innovative products in the segment.

Managing brands in the entire Dermocosmetic segment of three groups Ducray, A-Derma & Avene of Pierre Fabre, France.

Managing brands in the Dermocosmetic segment of two groups Ducray & A-Derma of Pierre Fabre, France.

Handling AT(DE) product portfolioLaunched first of its kind artificial tear formulation in India Optive FusionOptive Fusion adjudged as one on of the best launches of Allergan IndiaThe brand grossed in the first month of its launch achieving the highest ever sales figure by any brand launched by Allergan India till dateWorked on the laser sharp positioning & communication to break through the cluttered dry eye marketOptive Fusion won new introduction of the year Gold Award form AIOCD(AWACS)

Handled Nutraceuticals PortfolioHandled the pain portfolio of Aqura HG(Second largest division of Dr Reddys), specifically catering to the Orthopedicians...Launched first of its kind combination topical formulation in India ,licenced from Cymbiotics USA.Received the best new product product launch award in Dr ReddysPresently managing Stamlo a flagship brand of Dr Reddys ranked as no.1 brand in the amlodipine market & one of the top 150 brands of IPM Handling a portfolio size of Rs.600Mn in the Cradio Vascular Segment

Worked in the Cardio Diabeto division pegasus of Glaxo Smithkline....Looked after territories in Delhi & Haryana...worked as interface between PMT & Filed team...

To evaluate the potential of Boostrix(a reduced antigen Tdap vaccine of GSK) among General practitioners & Gynecologists